Market Cap 1.74B
Revenue (ttm) 0.00
Net Income (ttm) -103.69M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 862,700
Avg Vol 1,209,160
Day's Range N/A - N/A
Shares Out 59.80M
Stochastic %K 46%
Beta 0.33
Analysts Strong Sell
Price Target $40.62

Company Profile

Enliven Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of small molecule inhibitors to help patients with cancer. Its clinical programs comprise ELVN-001, a small molecule kinase inhibitor which is in Phase 1 clinical trial to treat adults with chronic myeloid leukemia; and ELVN-002, a central nervous system (CNS) penetrant and irreversible human epidermal growth factor receptor 2 inhibitor that is in Phase 1 clinical trial for the treatm...

Industry: Biotechnology
Sector: Healthcare
Phone: 720 647 8519
Address:
6200 Lookout Road, Boulder, United States
topstockalerts
topstockalerts Mar. 19 at 7:06 PM
$ELVN thinner and reactive, can spike hard on not much volume. Needs confirmation before chasing.
0 · Reply
AC_TRADER
AC_TRADER Mar. 19 at 6:24 PM
$ELVN trying to go... chart: https://share.trendspider.com/chart/ELVN/7594xstl26
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Mar. 18 at 12:52 PM
$ELVN RSI: 41.12, MACD: 0.5296 Vol: 1.39, MA20: 28.62, MA50: 26.73 🔴 SELL - Downtrend 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
GRASSFEDBEEF
GRASSFEDBEEF Mar. 5 at 2:20 PM
$ELVN The Enliven Therapeutics, Inc. stock price gained 4.28% on the last trading day (Wednesday, 4th Mar 2026), rising from $28.75 to $29.98. During the last trading day the stock fluctuated 9.01% from a day low at $27.97 to a day high of $30.49. The price has risen in 6 of the last 10 days and is up by 13.69% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 237 thousand more shares were traded than the day before. In total, 895 thousand shares were bought and sold for approximately $26.82 million. The stock lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 66.11% during the next 3 months and, with a 90% probability hold a price between $40.98 and $60.18 at the end of this 3-month period.
0 · Reply
d_risk
d_risk Mar. 3 at 9:53 PM
$ELVN - Enliven Therapeutics Inc - 10K - Updated Risk Factors ELVN’s 10-K sharpens risk around a single lead asset ELVN-001 (dropping ELVN-002 and licensing as core dependencies), adds FDA design/interpretation and companion diagnostic hurdles, introduces fresh going-concern-style and public-company burden risks, and broadens detail on team dependence, cyber/data, global ops, third parties, market volatility, and operational disruptions. #Biopharmaceuticals #DrugDevelopmentRisks #FDARegulatory #GoingConcern #Cybersecurity 🟢 Added 🟠 Removed https://d-risk.ai/ELVN/10-K/2026-03-03
0 · Reply
StockConsultant
StockConsultant Feb. 24 at 12:00 AM
$ELVN Enliven Therapeutics stock, nice setup and rally off the 25.85 triple support area, from Stocks to Watch at https://stockconsultant.com/?ELVN
0 · Reply
Sambong
Sambong Feb. 19 at 6:37 AM
$ELVN play safe ..over 30. ER on 3/12
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Feb. 12 at 6:51 PM
$ELVN RSI: 57.28, MACD: 1.6420 Vol: 1.10, MA20: 26.99, MA50: 22.12 🔴 SELL - Downtrend 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
thedentite
thedentite Feb. 6 at 6:46 PM
$ELVN Well will you look at that! What a great day
0 · Reply
DispersionX
DispersionX Feb. 4 at 1:49 PM
$ELVN is a clinical-stage biotech developing kinase inhibitors for inflammatory diseases; its lead candidate shows potential, but it is early in development with significant competition ahead.
0 · Reply
Latest News on ELVN
Enliven Therapeutics to Present at Upcoming Investor Conferences

May 22, 2025, 4:05 PM EDT - 10 months ago

Enliven Therapeutics to Present at Upcoming Investor Conferences


Final Trade: CVX, XLE, ELVN, COF

Mar 21, 2025, 6:38 PM EDT - 1 year ago

Final Trade: CVX, XLE, ELVN, COF

CVX XLE COF


Enliven's Early Data Stands Out From Peers

Jan 7, 2025, 12:28 AM EST - 1 year ago

Enliven's Early Data Stands Out From Peers


Why Enliven is this analyst's top biotech stock pick

Oct 18, 2024, 7:18 PM EDT - 1 year ago

Why Enliven is this analyst's top biotech stock pick


Imara Announces Stockholder Approval of Merger With Enliven

Feb 22, 2023, 4:01 PM EST - 3 years ago

Imara Announces Stockholder Approval of Merger With Enliven


Enliven Therapeutics and Imara Announce Merger Agreement

Oct 13, 2022, 4:35 PM EDT - 3 years ago

Enliven Therapeutics and Imara Announce Merger Agreement


Imara: Potential Liquidation

Sep 29, 2022, 3:06 PM EDT - 3 years ago

Imara: Potential Liquidation


Read Why Imara Shares Are Falling Today

Apr 5, 2022, 10:13 AM EDT - 4 years ago

Read Why Imara Shares Are Falling Today


Imara To Start Testing Tovinontrine In Heart Failure Patients

Jan 25, 2022, 11:03 AM EST - 4 years ago

Imara To Start Testing Tovinontrine In Heart Failure Patients


topstockalerts
topstockalerts Mar. 19 at 7:06 PM
$ELVN thinner and reactive, can spike hard on not much volume. Needs confirmation before chasing.
0 · Reply
AC_TRADER
AC_TRADER Mar. 19 at 6:24 PM
$ELVN trying to go... chart: https://share.trendspider.com/chart/ELVN/7594xstl26
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Mar. 18 at 12:52 PM
$ELVN RSI: 41.12, MACD: 0.5296 Vol: 1.39, MA20: 28.62, MA50: 26.73 🔴 SELL - Downtrend 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
GRASSFEDBEEF
GRASSFEDBEEF Mar. 5 at 2:20 PM
$ELVN The Enliven Therapeutics, Inc. stock price gained 4.28% on the last trading day (Wednesday, 4th Mar 2026), rising from $28.75 to $29.98. During the last trading day the stock fluctuated 9.01% from a day low at $27.97 to a day high of $30.49. The price has risen in 6 of the last 10 days and is up by 13.69% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 237 thousand more shares were traded than the day before. In total, 895 thousand shares were bought and sold for approximately $26.82 million. The stock lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 66.11% during the next 3 months and, with a 90% probability hold a price between $40.98 and $60.18 at the end of this 3-month period.
0 · Reply
d_risk
d_risk Mar. 3 at 9:53 PM
$ELVN - Enliven Therapeutics Inc - 10K - Updated Risk Factors ELVN’s 10-K sharpens risk around a single lead asset ELVN-001 (dropping ELVN-002 and licensing as core dependencies), adds FDA design/interpretation and companion diagnostic hurdles, introduces fresh going-concern-style and public-company burden risks, and broadens detail on team dependence, cyber/data, global ops, third parties, market volatility, and operational disruptions. #Biopharmaceuticals #DrugDevelopmentRisks #FDARegulatory #GoingConcern #Cybersecurity 🟢 Added 🟠 Removed https://d-risk.ai/ELVN/10-K/2026-03-03
0 · Reply
StockConsultant
StockConsultant Feb. 24 at 12:00 AM
$ELVN Enliven Therapeutics stock, nice setup and rally off the 25.85 triple support area, from Stocks to Watch at https://stockconsultant.com/?ELVN
0 · Reply
Sambong
Sambong Feb. 19 at 6:37 AM
$ELVN play safe ..over 30. ER on 3/12
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Feb. 12 at 6:51 PM
$ELVN RSI: 57.28, MACD: 1.6420 Vol: 1.10, MA20: 26.99, MA50: 22.12 🔴 SELL - Downtrend 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
thedentite
thedentite Feb. 6 at 6:46 PM
$ELVN Well will you look at that! What a great day
0 · Reply
DispersionX
DispersionX Feb. 4 at 1:49 PM
$ELVN is a clinical-stage biotech developing kinase inhibitors for inflammatory diseases; its lead candidate shows potential, but it is early in development with significant competition ahead.
0 · Reply
BobBobbertonnn
BobBobbertonnn Feb. 2 at 9:18 PM
1 · Reply
thedentite
thedentite Feb. 2 at 8:06 PM
$ELVN Another great day. What's not to like?
0 · Reply
thedentite
thedentite Feb. 1 at 12:52 AM
$ELVN This company is going places.
0 · Reply
justiceforb_85
justiceforb_85 Jan. 28 at 2:59 AM
$ELVN remains undervalued.
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Jan. 23 at 3:37 AM
$ELVN RSI: 85.29, MACD: 2.3782 Vol: 5.28, MA20: 20.85, MA50: 20.33 🔴 SELL - Downtrend 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
Sw1ngb0t
Sw1ngb0t Jan. 23 at 1:10 AM
0 · Reply
thedentite
thedentite Jan. 22 at 3:14 PM
$ELVN Big green candle. Nice
0 · Reply
thedentite
thedentite Jan. 21 at 6:41 PM
$ELVN I love the gentle movement up.
1 · Reply
thedentite
thedentite Jan. 16 at 6:38 PM
$ELVN Bearish sentiment? Ha
1 · Reply
blue81
blue81 Jan. 16 at 6:52 AM
$ELVN 33$ is coming in this quarter
0 · Reply
Jimbates22
Jimbates22 Jan. 14 at 6:45 PM
$ELVN green to red. A sign that the pump is over.
0 · Reply
Jimbates22
Jimbates22 Jan. 14 at 5:51 PM
$ELVN looks like they are setting up for an offering. Insiders dumping
1 · Reply